PharmaShots | Incisive News in 3 Shots

Subscribe Now

Dialectic Therapeutics

Dialectic Therapeutics’ DT2216 Receives the US FDA’s Orphan Drug Designation for the Treatment of T-Cell Lymphoma

Dialectic Therapeutics’ DT2216 Receives the US FDA’s Orphan Drug Designation for the Treatment of T-Cell Lymphoma

March 15, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us